CADTH recommends that public drug strategies reimburse Hemgenix with the therapy of hemophilia B if specified disorders are met. Based on the clinical industry experts consulted by CADTH, there are several unmet needs for hemophilia B. To start with, individuals with hemophilia B have a lifestyle